Related Experiment Video
Updated: Jun 17, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Monitoring and management of heparin-induced thrombocytopenia
Abstract:
Low molecular weight heparins have been used to reduce thromboembolic risk for at least 20 years, but their use is not without risk. This article considers the incidence, monitoring, treatment and lack of insight about heparin-induced thrombocytopenia - a potentially fatal complication of low molecular weight heparin use.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Therapeutic Drug Monitoring: Overview and Classification